marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Verona Pharma plc Financial Statements 2011-2024 | VRNA
Annual Financial Statements Verona Pharma plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
11 B | 10.8 B | 3.18 B | 261 M | 72.5 M | 77.6 M | 141 M | - | - | - | - | - | - |
Shares |
634 M | 529 M | 473 M | 33 M | 13 M | 13 M | 11 M | - | - | - | - | - | - |
Historical Prices |
17.4 | 20.4 | 6.72 | 7 | 5.75 | 9.65 | 11.9 | - | - | - | - | - | - |
Net Income |
-54.4 M | -68.7 M | -55.6 M | -65.1 M | - | - | - | -6.19 M | -11 M | -4.29 M | -4.16 M | -4.07 M | -2.67 M |
Revenue |
- | 458 K | 40 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 346 K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 112 K | 40 M | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-67.6 M | -75.8 M | -73.3 M | -74.3 M | -52.4 M | - | - | - | - | - | - | - | - |
Interest Expense |
2.06 M | 521 K | 340 K | 35 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-66.9 M | -75.1 M | -72.7 M | -65 M | 398 K | 8 K | 7 K | -8.5 M | -13.2 M | -5.82 M | -4.58 M | -4.13 M | -2.82 M |
Operating Expenses |
67.6 M | 75.9 M | 113 M | 74.3 M | 53.4 M | 32.5 M | -40.3 M | - | - | - | - | - | - |
General and Administrative Expenses |
50.4 M | 26.6 M | 33.9 M | 29.8 M | 4.94 M | 3.39 M | -8.17 M | 1.62 M | 1.36 M | 1.8 M | 1.91 M | 1.47 M | 1.12 M |
All numbers in USD currency
Quarterly Income Statement Verona Pharma plc
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
652 M | 648 M | 644 M | 638 M | 634 M | 621 M | 606 M | 544 M | 485 M | 482 M | 480 M | 475 M | 471 M | 469 M | 463 M | 345 M | 106 M | 105 M | 105 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-43 M | -70.8 M | - | -14.7 M | -8.81 M | -16.7 M | - | -15.6 M | -17.8 M | -24.8 M | - | 11.1 M | -22.1 M | -21.3 M | - | -18.9 M | -9.04 M | -12.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
5.62 M | - | - | - | - | - | - | - | - | - | - | 40 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | 40 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-40.7 M | -68.4 M | - | -16.3 M | -9.96 M | -22.2 M | - | -15.1 M | -20.5 M | -25.1 M | - | 6.56 M | -28.5 M | -22.9 M | - | -21.1 M | -11 M | -14.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
9.88 M | 1.76 M | - | 401 K | 740 K | 293 K | - | 116 K | 91 K | 84 K | - | 86 K | 85 K | 84 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | -22 M | - | -14.6 M | -20.2 M | -24.9 M | - | 7.02 M | -28.2 M | -22.7 M | - | -20.6 M | -10.7 M | -14.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
46.3 M | 68.4 M | - | 16.3 M | 9.96 M | 22.2 M | - | 15.1 M | 20.5 M | 25.1 M | - | 33.4 M | 28.5 M | 22.9 M | - | 21.1 M | 11 M | 14.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
35.2 M | 49 M | - | 13.4 M | 12.4 M | 9.59 M | - | 5.29 M | 5.53 M | 7.44 M | - | 10.9 M | 7.98 M | 9.28 M | - | 8.28 M | 3.17 M | 6.86 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency